Overview of Malignant Giloma: Management and Novel Therapies - Charles S. Cobbs, M.D.
http://www.seattlesciencefoundation.org Seattle Science Foundation is a non-profit organization dedicated to the international collaboration among physicians, ...
Seattle Science Foundation
Engineering T cells: moving beyond leukemia
Engineering T cells: moving beyond leukemia Air date: Wednesday, September 28, 2016, 3:00:00 PM Category: WALS - Wednesday Afternoon Lectures ...
NIH VideoCast
Ohio State Study Reveals Drivers of Immune Evasion, Cancer Progression
Columbus, Ohio – A new study led by researchers at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard ...
Ohio State University Comprehensive Cancer Center-James Cancer Hospital & Solove Research Institute
Novel therapy for Lung Cancer: From targeted therapy to immuno-therapy and back again!
Speaker: Roy S. Herbst, MD, P.hD. Ensign Professor of Medicine Professor of Pharmacology; Chief of Medical Oncology Director Thoracic Oncology Research ...
Yale Radiology and Biomedical Imaging
Debate: Targeting the immune system with checkpoint inhibitors - Combination therapy
In this presentation from the 21st Annual Perspectives in Thoracic Oncology, Dr. Vassiliki Papadimitrakopoulou argues in favor of the use of combination therapy ...
ImedexCME
Ed Forum Chat Series: Understanding Immunotherapy
Ed Forum Chat Series: Sunday, October 20, 2019 - Morning Plenary at the North American Educational Forum on Lymphoma 1. Immunotherapy Overview with ...
Lymphoma Research Foundation
Immune Checkpoint Inhibitors in Hodgkin and non-Hodgkin Lymphoma
For the past fifteen years, Lymphoma & Myeloma has been the premier forum on the latest advances in lymphoma, myeloma, and other plasma cell neoplasms.
ImedexCME
Monitoring, managing, and mitigating immune-related adverse events
In this presentation from the 22nd Annual Perspectives in Thoracic Oncology, Dr. Lyudmila Bazhenova discusses monitoring, managing, and mitigating ...
ImedexCME
Primary cell isolation for drug discovery assays [WEBINAR]
For more information, visit https://www.miltenyibiotec.com/lp/2018/us-multimacsx.html Get your drug discovery research program off to the right start with reliable ...
Miltenyi Biotec
Key Insights: Breast Cancer
Advancements in breast cancer care continue to rapidly evolve and the San Antonio Breast Cancer Symposium (SABCS) is the premier annual forum for ...
ImedexCME
Systemic Therapy for Advanced Melanoma
Ahmad Tarhini, MD, PhD, talks about systemic therapy for advanced melanoma. The presentation is part of the AIM at Melanoma's Patient & Caregiver ...
AIMatMelanoma
Oxford University surgical lectures: Diagnosing and managing early prostate cancer
Mr Vincent Gnanapragasam from the University of Cambridge presents 'Using research to change paradigms in diagnosing and managing early prostate ...
surgicalsciences
Dr. Bullock - Mitogenic Signaling of Tumor Suppressor Genes in Pancreatic Cancer
Dr. Bullock's presentation focused on her research aimed at characterizing the clinical, pathologic, and genetic characteristics of the pancreatic cancer patient ...
HirshbergFoundation
Minimally invasive surgery for cancer of the esophagus
In this presentation from the ESMO 19th World Congress on Gastrointestinal Cancer, Dr. Christophe Mariette discusses minimally invasive surgery for cancer of ...
ImedexCME
The Current Understanding of Biomarkers in Melanoma
OncLiveTV
TRACO 2017 - Ovarian Cancer in the Genomics Era and Immune checkpoints
TRACO 2017 - Ovarian Cancer in the Genomics Era and Immune checkpoints Air date: Monday, September 25, 2017, 4:00:00 PM Category: TRACO Runtime: ...
NIH VideoCast
Keynote - Cancer Immunology (Carl H. June)
Introduction: Steven J. Burakoff, Dean for Cancer Innovation; Lillian and Henry M. Stratton Professor of Cancer Medicine, Icahn School of Medicine at Mount ...
Icahn School of Medicine
Emilee Knowlton: Epitope identification & clinical immune monitoring in gene therapy & IO programs
Epitope discovery is a crucial element in the development of vaccine candidates and drug therapeutics. In the Immune-oncology space, identifying neoepitopes ...
ProImmune thinkpeptides
Patrick Dillon - FUS therapy combined with pembrolizumab in metastatic breast cancer (2018)
Focused ultrasound therapy combined with pembrolizumab in metastatic breast cancer.
Focused Ultrasound Foundation - Symposium Research Talks
LAM: Treatment Options and Clinical Trials
This session was videotaped during the 2018 World TSC Conference, held in in Dallas, TX, July 25-29 and co-hosted by the Tuberous Sclerosis Alliance and ...
Tuberous Sclerosis Alliance
TKI-resistant EGFR-mutant NSCLC
Filmed on location in Las Vegas during the 21st Annual NOCR Meeting, this webcast is part of a series that provides expert discussions from physicians and ...
ImedexCME
Breast Cancer: New Treatments & Improved Therapies - Milestones in Oncology
A dialogue with Dr. Larry Norton and Dr. Bruce Chabner First in the series, the Norton-Simon collaboration has led, on the one hand, to an improved ...
The Society for Translational Oncology
Multiple PD-1/PD-L1 Agents in Lung Cancer
Panelists discuss several PD-1 and PD-L1 inhibitors being explored as treatments for patients with non-small cell lung cancer.
OncLiveTV
Redefining Success and Failure in Cancer Immunotherapy Trials
http://cancerGRACE.org/ Immunotherapy Forum Video #30: Immunotherapy for cancer has rewritten the rules for what we consider a successful response to ...
GRACE - Global Resource for Advancing Cancer Education
From NASA to MSK: Exercise Oncology
In this introduction to the new field of exercise oncology, Dr. Jessica Scott will discuss her research examining how NASA's countermeasures program may help ...
Memorial Sloan Kettering
Weekly Webinar Series Part 2: Managing Lung Cancer Patients Through the COVID-19 Pandemic
Led by Nathan Pennell, MD, PhD; Stephen Liu, MD; Charu Aggarwal, MD, MPH; and H. Jack West, MD, this webinar will cover all of the key information on ...
OncLiveTV
Hepatitis B and Liver Cancer: Prevention and Treatment
The rate of deaths due to liver cancer is increasing faster than any other type of cancer. Hepatitis B and C are major contributing factors to liver cancer. At this ...
InHealth: A Washington Hospital Channel
Combination of viroimmunotherapy with checkpoint inhibitors
Prof Alan Melcher speaks with ecancertv about his research into oncolytic viruses as immunotherapy - reprogramming infectious agents to reach inaccessible ...
ecancer
Innovative Approaches to Brain Tumor Management by Charles Cobbs, MD
Innovative Approaches to Brain Tumor Management was presented by Charles Cobbs, MD at the Innovative Approaches to Brain Tumor Management Course ...
Seattle Science Foundation
Webinar: Michael Lim, MD - Immunotherapy for Brain Tumors
Michael Lim, MD, from Johns Hopkins University discusses the mechanisms of “kindling” and reviews the state of multimodal immunotherapy in some of the ...
Focused Ultrasound Foundation
Rheumatology, Immunology, and Immuno-Oncology Intersect: Navigating the Complexities of irAEs
Leonard H. Calabrese, DO, and Evan J. Lipson, MD, discuss rheumatology in this CME/MOC/CNE activity titled "Rheumatology, Immunology, and ...
PeerView CME
PD-1/PD-L1 Inhibitors Explored Across NSCLC Settings
In this segment, panelists discuss the exploration of PD-1 and PD-L1 inhibitors across a variety of settings for patients with non-small cell lung cancer.
OncLiveTV
Keynote: Curing Cancer by 2025 - Gary Gilliland, MD, PhD
Seattle Cancer Care Alliance Immunotherapy Symposium, 2018 Keynote: Curing Cancer by 2025 Gary Gilliland, MD, PhD President and Director, Fred ...
Seattle Cancer Care Alliance
From Genes to Personalized Medicine: Innovations in Bladder Cancer Research - Chin - LA
Arnold Chin, MD, PhD, UCLA LA Patient Forum Click here for more information: http://www.bcan.org/
Bladder Cancer Advocacy Network
Medically Speaking: Cancer Clinical Trials, Stacey L. Berg, MD
Texas Children's Hospital, located in Houston, Texas, is one of the nation's largest children's hospitals, consistently ranked across all subspecialties by ...
Texas Children’s Hospital
NSCLC: Immunotherapy Beyond Progression
Panelists Suresh S. Ramalingam, MD; Benjamin Besse, MD, PhD; Giorgio Scagliotti, MD, PhD; and Marina Garassino, MD, discuss the approach of ...
OncLiveTV
The Role of the Pathologist in the Treatment of the Pituitary Patient
Presented by Sylvia Asa, MD, PhD Professor, Department of Laboratory Medicine and Pathobiology University of Toronto Learning Objectives: To understand ...
pnainfo
Winship Grand Rounds March 8, 2017: Robert Ferris, MD, PhD
Robert Ferris, MD, PhD of Univesity of Pittsburgh Cancer Center presented "Applying Translational and Clinical Research for Optimal Therapeutic Targeting of ...
Winship Cancer Institute of Emory University
The Impact of the COVID-19 Pandemic on Laboratory and Testing Practices
Presenters: John W. Longshore, Ph.D., FACMG; Carolyn Compton, MD, PhD, FCAP; Kimberly W. Sanford, M.D. Sponsors: AstraZeneca, ASCP Topic: The Impact ...
OncLiveTV
New Data for Checkpoint Inhibitors in NSCLC
Panelists Mark Socinski, MD; Tracey Evans, MD; Alexander Drilon, MD; Vali Papadimitrakopoulou, MD; and Jared Weiss, MD, review data that have tested the ...
OncLiveTV
Graft-Versus-Host Disease/Graft-Versus-Leukemia: Recent Advances in Therapy
"Graft-Versus-Host Disease/Graft-Versus-Leukemia: Recent Advances in Therapy" Monday, July 22, 2014 at 4 p.m. Presented by Edward Peres, M.D. About the ...
HenryFordTV
Critical Advances in Immunotherapy for Kidney Cancer, with Nizar Tannir
On March 16, 2016, Nizar M. Tannir, M.D., FACP, professor and deputy chair of the department of genitourinary medical oncology at The University of Texas MD ...
Cancer Research Institute
![Cancer treatment and research. [Vol.] 14 : Basic and clinical tumor immunology](https://static.rusist.info/screens/009/174/810.jpg)
